Our genetic heritage is not a blueprint or an algorithm, as many biologists have imagined, but something else entirely.

I think we should go back a little bit to the pathophysiology of the disease, because this is largely driven by ...

GLP-1 receptor agonists are currently among the most widely discussed classes of drugs worldwide. They have gained popularity ...